Publications by authors named "Chad Vandenberg"

Claim this Profile
V
Virtual Transition of Care Clinics and Associated Readmission Rates: 3-Year Retrospective Cohort Study.
Sarah F Horman, Milla Kviatkovsky, Edward Castillo, Patricia Maysent, Chad VanDenBerg

JMIR Med Inform· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large Language Models for More Efficient Reporting of Hospital Quality Measures.
Aaron Boussina, Rishivardhan Krishnamoorthy, Kimberly Quintero, Shreyansh Joshi, Gabriel Wardi, Chad VanDenBerg

NEJM AI· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New Era for the Patient Safety Imperative.
Chad VanDenBerg

J Healthc Manag· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practitioner Application: Patient Safety Climate: A Study of Southern California Healthcare Organizations.
Chad E VanDenBerg

J Healthc Manag· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an enantioselective assay for simultaneous separation of venlafaxine and O-desmethylvenlafaxine by micellar electrokinetic chromatography-tandem mass spectrometry: Application to the analysis of drug-drug interaction.
Yijin Liu, Michael Jann, Chad Vandenberg, Chin B Eap, Shahab A Shamsi

J Chromatogr A· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The transdermal delivery system of monoamine oxidase inhibitors.
Chad M VanDenBerg

J Clin Psychiatry· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discussion: a fresh look at monoamine oxidase inhibitors for depression.
Lawrence J Cohen, David A Sclar, Larry Culpepper, David A Flockhart, Robert M A Hirschfeld, Chad M VanDenBerg

J Clin Psychiatry· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MAOIs and transdermal delivery.
Chad M Vandenberg

J Clin Psychiatry· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of a pharmacokinetic drug-drug interaction with venlafaxine extended-release/indinavir and desvenlafaxine extended-release/indinavir.
Michael W Jann, Vicky Spratlin, Kathryn Momary, Hailing Zhang, David Turner, Chad VanDenBerg

Eur J Clin Pharmacol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy.
Alan Wright, Kyle E Luedtke, Chad Vandenberg

J Pain Res· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duloxetine in the treatment of generalized anxiety disorder.
Alan Wright, Chad Vandenberg

Int J Gen Med· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disposition of D-serine in healthy adults.
Guochuan E Tsai, Hsien-Yuan Lane, Chad M Vandenberg, Yi-Ching Liu, Priscilla Tsai

J Clin Pharmacol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and absolute bioavailability of selegiline following treatment of healthy subjects with the selegiline transdermal system (6 mg/24 h): a comparison with oral selegiline capsules.
Albert J Azzaro, John Ziemniak, Eva Kemper, Bryan J Campbell, Chad VanDenBerg

J Clin Pharmacol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the potential for pharmacodynamic and pharmacokinetic drug interactions between selegiline transdermal system and two sympathomimetic agents (pseudoephedrine and phenylpropanolamine) in healthy volunteers.
Albert J Azzaro, Chad M VanDenBerg, John Ziemniak, Eva M Kemper, Lawrence F Blob

J Clin Pharmacol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selegiline transdermal system: an examination of the potential for CYP450-dependent pharmacokinetic interactions with 3 psychotropic medications.
Albert J Azzaro, John Ziemniak, Eva Kemper, Bryan J Campbell, Chad VanDenBerg

J Clin Pharmacol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of a tyramine-enriched meal on blood pressure response in healthy male volunteers treated with selegiline transdermal system 6 mg/24 hour.
Lawrence F Blob, Melvin Sharoky, Bryan J Campbell, Eva M Kemper, Michelle Gilmor Gilmor, Chad M VanDenberg

CNS Spectr· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tyramine pressor sensitivity during treatment with the selegiline transdermal system 6 mg/24 h in healthy subjects.
Albert J Azzaro, Chad M Vandenberg, Lawrence F Blob, Eva M Kemper, Melvin Sharoky

J Clin Pharmacol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tyramine pharmacokinetics and reduced bioavailability with food.
Chad M VanDenBerg, Lawrence F Blob, Eva M Kemper, Albert J Azzaro

J Clin Pharmacol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of fluvoxamine in relation to CYP2C19 phenotype and genotype.
Michael W Jan, Troy L ZumBrunnen, Yusuf R Kazmi, Chad M VanDenBerg, Hiral D Desai

Drug Metabol Drug Interact· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis